Mutation of foxl1 Results in Reduced Cartilage Markers in a Zebrafish Model of Otosclerosis

Genes (Basel). 2022 Jun 21;13(7):1107. doi: 10.3390/genes13071107.

Abstract

Bone diseases such as otosclerosis (conductive hearing loss) and osteoporosis (low bone mineral density) can result from the abnormal expression of genes that regulate cartilage and bone development. The forkhead box transcription factor FOXL1 has been identified as the causative gene in a family with autosomal dominant otosclerosis and has been reported as a candidate gene in GWAS meta-analyses for osteoporosis. This potentially indicates a novel role for foxl1 in chondrogenesis, osteogenesis, and bone remodelling. We created a foxl1 mutant zebrafish strain as a model for otosclerosis and osteoporosis and examined jaw bones that are homologous to the mammalian middle ear bones, and mineralization of the axial skeleton. We demonstrate that foxl1 regulates the expression of collagen genes such as collagen type 1 alpha 1a and collagen type 11 alpha 2, and results in a delay in jawbone mineralization, while the axial skeleton remains unchanged. foxl1 may also act with other forkhead genes such as foxc1a, as loss of foxl1 in a foxc1a mutant background increases the severity of jaw calcification phenotypes when compared to each mutant alone. Our zebrafish model demonstrates atypical cartilage formation and mineralization in the zebrafish craniofacial skeleton in foxl1 mutants and demonstrates that aberrant collagen expression may underlie the development of otosclerosis.

Keywords: bone mineral density; collagen; foxc1; foxl1; iron binding; osteoporosis; otosclerosis; zebrafish.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biomarkers / metabolism
  • Cartilage
  • Mammals
  • Mutation
  • Osteoporosis*
  • Otosclerosis* / genetics
  • Zebrafish / genetics
  • Zebrafish / metabolism

Substances

  • Biomarkers

Grants and funding

This research was funded through the Medical Research Fund at Memorial University (Curtis French) and the Atlantic Canada Opportunities Agency—Community Innovation Fund (Terry-Lynn Young). Alexia Hawkey-Noble is supported by the Dean’s Fellowship (Memorial University).